Jason E. Drury

913 total citations
15 papers, 755 citations indexed

About

Jason E. Drury is a scholar working on Cell Biology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jason E. Drury has authored 15 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cell Biology, 6 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jason E. Drury's work include Aldose Reductase and Taurine (8 papers), Hormonal and reproductive studies (4 papers) and Prenatal Substance Exposure Effects (4 papers). Jason E. Drury is often cited by papers focused on Aldose Reductase and Taurine (8 papers), Hormonal and reproductive studies (4 papers) and Prenatal Substance Exposure Effects (4 papers). Jason E. Drury collaborates with scholars based in United States, Australia and Spain. Jason E. Drury's co-authors include T.M. Penning, David W. Christianson, Luigi Di Costanzo, Mo Chen, Lawrence H. Pinto, Jorgen Mould, Andrew Pekosz, Stephan Frings, U. Benjamin Kaupp and Robert A. Lamb and has published in prestigious journals such as Journal of Biological Chemistry, Archives of Biochemistry and Biophysics and British Journal of Haematology.

In The Last Decade

Jason E. Drury

15 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason E. Drury United States 13 371 263 164 104 101 15 755
Kaoru Nishiyama Japan 14 710 1.9× 198 0.8× 38 0.2× 28 0.3× 120 1.2× 33 1.1k
Andrea Verhagen United States 14 738 2.0× 91 0.3× 104 0.6× 174 1.7× 44 0.4× 19 1.5k
Robert R. Lavieri United States 11 440 1.2× 114 0.4× 30 0.2× 39 0.4× 37 0.4× 17 685
Margaret Doherty Ireland 11 539 1.5× 94 0.4× 44 0.3× 58 0.6× 25 0.2× 18 706
B. Gonzalez United States 13 588 1.6× 293 1.1× 27 0.2× 58 0.6× 59 0.6× 20 1.0k
James M. Fujitaki United States 18 585 1.6× 60 0.2× 218 1.3× 267 2.6× 27 0.3× 34 1.2k
Н. В. Проказова Russia 16 617 1.7× 148 0.6× 53 0.3× 92 0.9× 17 0.2× 60 884
Seigo Shumiya Japan 15 396 1.1× 139 0.5× 53 0.3× 73 0.7× 42 0.4× 45 801
Masamitsu Kanai Japan 9 725 2.0× 188 0.7× 75 0.5× 57 0.5× 62 0.6× 30 1.0k
B C Pramanik United States 17 694 1.9× 143 0.5× 88 0.5× 85 0.8× 19 0.2× 23 1.1k

Countries citing papers authored by Jason E. Drury

Since Specialization
Citations

This map shows the geographic impact of Jason E. Drury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Drury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Drury more than expected).

Fields of papers citing papers by Jason E. Drury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason E. Drury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Drury. The network helps show where Jason E. Drury may publish in the future.

Co-authorship network of co-authors of Jason E. Drury

This figure shows the co-authorship network connecting the top 25 collaborators of Jason E. Drury. A scholar is included among the top collaborators of Jason E. Drury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason E. Drury. Jason E. Drury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Powers, Alicia, Jason E. Drury, Christopher F. Hoehamer, Timothy Lockey, & Michael M. Meagher. (2020). Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor. Molecular Therapy — Methods & Clinical Development. 19. 1–13. 21 indexed citations
2.
Piras, Bryan A., Jason E. Drury, Christopher L. Morton, et al.. (2016). Distribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vector. Molecular Therapy — Methods & Clinical Development. 3. 16015–16015. 21 indexed citations
3.
Drury, Jason E., et al.. (2015). Catalytic Properties of Intramembrane Aspartyl Protease Substrate Hydrolysis Evaluated Using a FRET Peptide Cleavage Assay. ACS Chemical Biology. 10(9). 2166–2174. 11 indexed citations
4.
Yu, Yi, Teresa Mena‐Barragán, Katsumi Higaki, et al.. (2014). Molecular Basis of 1-Deoxygalactonojirimycin Arylthiourea Binding to Human α-Galactosidase A: Pharmacological Chaperoning Efficacy on Fabry Disease Mutants. ACS Chemical Biology. 9(7). 1460–1469. 47 indexed citations
5.
Chen, Mo, Jason E. Drury, David W. Christianson, & T.M. Penning. (2012). Conversion of Human Steroid 5β-Reductase (AKR1D1) into 3β-Hydroxysteroid Dehydrogenase by Single Point Mutation E120H. Journal of Biological Chemistry. 287(20). 16609–16622. 19 indexed citations
6.
Culver, Jeffrey A., et al.. (2011). Conversion of scFv peptide-binding specificity for crystal chaperone development. Protein Engineering Design and Selection. 24(5). 419–428. 11 indexed citations
7.
Chen, Mo, Jason E. Drury, & T.M. Penning. (2011). Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1). Steroids. 76(5). 484–490. 42 indexed citations
8.
Drury, Jason E., Rebekka Mindnich, & T.M. Penning. (2010). Characterization of Disease-related 5β-Reductase (AKR1D1) Mutations Reveals Their Potential to Cause Bile Acid Deficiency. Journal of Biological Chemistry. 285(32). 24529–24537. 38 indexed citations
9.
Mindnich, Rebekka, Jason E. Drury, & T.M. Penning. (2010). The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function. Chemico-Biological Interactions. 191(1-3). 250–254. 13 indexed citations
10.
Drury, Jason E., Luigi Di Costanzo, T.M. Penning, & David W. Christianson. (2009). Inhibition of Human Steroid 5β-Reductase (AKR1D1) by Finasteride and Structure of the Enzyme-Inhibitor Complex. Journal of Biological Chemistry. 284(30). 19786–19790. 54 indexed citations
11.
Costanzo, Luigi Di, Jason E. Drury, David W. Christianson, & T.M. Penning. (2008). Structure and catalytic mechanism of human steroid 5β-reductase (AKR1D1). Molecular and Cellular Endocrinology. 301(1-2). 191–198. 32 indexed citations
12.
Costanzo, Luigi Di, Jason E. Drury, T.M. Penning, & David W. Christianson. (2008). Crystal Structure of Human Liver Δ4-3-Ketosteroid 5β-Reductase (AKR1D1) and Implications for Substrate Binding and Catalysis. Journal of Biological Chemistry. 283(24). 16830–16839. 63 indexed citations
13.
Penning, T.M. & Jason E. Drury. (2007). Human aldo–keto reductases: Function, gene regulation, and single nucleotide polymorphisms. Archives of Biochemistry and Biophysics. 464(2). 241–250. 222 indexed citations
14.
Mould, Jorgen, Jason E. Drury, Stephan Frings, et al.. (2000). Permeation and Activation of the M2 Ion Channel of Influenza A Virus. Journal of Biological Chemistry. 275(40). 31038–31050. 127 indexed citations
15.
Roberts, J. J., Susan Rodgers, Jason E. Drury, Leonie K. Ashman, & J. V. Lloyd. (1995). Platelet activation induced by a murine monoclonal antibody directed against a novel tetra‐span antigen. British Journal of Haematology. 89(4). 853–860. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026